117 related articles for article (PubMed ID: 25754611)
1. Clinicopathologic significance of BubR1 and Mad2 overexpression in oral cancer.
Teixeira JH; Silva P; Faria J; Ferreira I; Duarte P; Delgado ML; Queirós O; Moreira R; Barbosa J; Lopes CA; do Amaral JB; Monteiro LS; Bousbaa H
Oral Dis; 2015 Sep; 21(6):713-20. PubMed ID: 25754611
[TBL] [Abstract][Full Text] [Related]
2. MAD2 expression in oral squamous cell carcinoma and its relationship to tumor grade and proliferation.
Rizzardi C; Torelli L; Schneider M; Giudici F; Zandona L; Biasotto M; Di Lenarda R; Melato M
Anticancer Res; 2014 Dec; 34(12):7021-7. PubMed ID: 25503128
[TBL] [Abstract][Full Text] [Related]
3. Spindle assembly checkpoint protein expression correlates with cellular proliferation and shorter time to recurrence in ovarian cancer.
McGrogan B; Phelan S; Fitzpatrick P; Maguire A; Prencipe M; Brennan D; Doyle E; O'Grady A; Kay E; Furlong F; McCann A
Hum Pathol; 2014 Jul; 45(7):1509-19. PubMed ID: 24792619
[TBL] [Abstract][Full Text] [Related]
4. BubR1 Acts as a Promoter in Cellular Motility of Human Oral Squamous Cancer Cells through Regulating MMP-2 and MMP-9.
Chou CK; Wu CY; Chen JY; Ng MC; Wang HM; Chen JH; Yuan SS; Tsai EM; Chang JG; Chiu CC
Int J Mol Sci; 2015 Jul; 16(7):15104-17. PubMed ID: 26151845
[TBL] [Abstract][Full Text] [Related]
5. High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma.
Moura IM; Delgado ML; Silva PM; Lopes CA; do Amaral JB; Monteiro LS; Bousbaa H
J Oral Pathol Med; 2014 Mar; 43(3):225-31. PubMed ID: 24044615
[TBL] [Abstract][Full Text] [Related]
6. Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells.
Bargiela-Iparraguirre J; Prado-Marchal L; Pajuelo-Lozano N; Jiménez B; Perona R; Sánchez-Pérez I
Cell Cycle; 2014; 13(22):3590-601. PubMed ID: 25483095
[TBL] [Abstract][Full Text] [Related]
7. BUBR1 expression in benign oral lesions and squamous cell carcinomas: correlation with human papillomavirus.
Lira RC; Miranda FA; Guimarães MC; Simões RT; Donadi EA; Soares CP; Soares EG
Oncol Rep; 2010 Apr; 23(4):1027-36. PubMed ID: 20204288
[TBL] [Abstract][Full Text] [Related]
8. Checkpoint protein BubR1 acts synergistically with Mad2 to inhibit anaphase-promoting complex.
Fang G
Mol Biol Cell; 2002 Mar; 13(3):755-66. PubMed ID: 11907259
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Mad2 and BubR1 increase the malignant potential and nocodazole resistance by compromising spindle assembly checkpoint signaling pathway in cervical carcinogenesis.
Wang L; Wang J; Jin Y; Zheng J; Yang Y; Xi X
J Obstet Gynaecol Res; 2019 Dec; 45(12):2407-2418. PubMed ID: 31523901
[TBL] [Abstract][Full Text] [Related]
10. Tripeptidyl peptidase II in human oral squamous cell carcinoma.
Usukura K; Kasamatsu A; Okamoto A; Kouzu Y; Higo M; Koike H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
J Cancer Res Clin Oncol; 2013 Jan; 139(1):123-30. PubMed ID: 22986808
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous reduction of MAD2 and BUBR1 expression induces mitotic spindle alterations associated with p53 dependent cell cycle arrest and death.
Lentini L; Piscitello D; Veneziano L; Di Leonardo A
Cell Biol Int; 2014 Aug; 38(8):933-41. PubMed ID: 24687487
[TBL] [Abstract][Full Text] [Related]
12. Expression of BUBR1 in human oral potentially malignant disorders and squamous cell carcinoma.
Hsieh PC; Chen YK; Tsai KB; Shieh TY; Chang YY; Chang JG; Wu HL; Lin SF
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb; 109(2):257-67. PubMed ID: 19926498
[TBL] [Abstract][Full Text] [Related]
13. Mammalian mad2 and bub1/bubR1 recognize distinct spindle-attachment and kinetochore-tension checkpoints.
Skoufias DA; Andreassen PR; Lacroix FB; Wilson L; Margolis RL
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4492-7. PubMed ID: 11274370
[TBL] [Abstract][Full Text] [Related]
14. Expression of spindle assembly checkpoint proteins BubR1 and Mad2 expression as potential biomarkers of malignant transformation of oral leukoplakia: an observational cohort study.
Monteiro L; Silva P; Delgado L; Amaral B; Garcês F; Salazar F; Pacheco JJ; Lopes C; Bousbaa H; Warnakulasuriya S
Med Oral Patol Oral Cir Bucal; 2021 Nov; 26(6):e719-e728. PubMed ID: 34704983
[TBL] [Abstract][Full Text] [Related]
15. Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy.
Tanaka K; Mohri Y; Ohi M; Yokoe T; Koike Y; Morimoto Y; Miki C; Tonouchi H; Kusunoki M
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):639-46. PubMed ID: 18691855
[TBL] [Abstract][Full Text] [Related]
16. Intermediates in the assembly of mitotic checkpoint complexes and their role in the regulation of the anaphase-promoting complex.
Kaisari S; Sitry-Shevah D; Miniowitz-Shemtov S; Hershko A
Proc Natl Acad Sci U S A; 2016 Jan; 113(4):966-71. PubMed ID: 26755599
[TBL] [Abstract][Full Text] [Related]
17. BUBR1 expression in oral squamous cell carcinoma and its relationship to tumor stage and survival.
Rizzardi C; Torelli L; Barresi E; Schneider M; Canzonieri V; Biasotto M; Di Lenarda R; Melato M
Head Neck; 2011 May; 33(5):727-33. PubMed ID: 21069850
[TBL] [Abstract][Full Text] [Related]
18. 6,7-Dimethoxy-3-(3-methoxyphenyl)isoquinolin-1-amine induces mitotic arrest and apoptotic cell death through the activation of spindle assembly checkpoint in human cervical cancer cells.
Chung KS; Choi HE; Shin JS; Cho YW; Choi JH; Cho WJ; Lee KT
Carcinogenesis; 2013 Aug; 34(8):1852-60. PubMed ID: 23615402
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation.
Grabsch H; Takeno S; Parsons WJ; Pomjanski N; Boecking A; Gabbert HE; Mueller W
J Pathol; 2003 May; 200(1):16-22. PubMed ID: 12692836
[TBL] [Abstract][Full Text] [Related]
20. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.
Cheng AN; Jiang SS; Fan CC; Lo YK; Kuo CY; Chen CH; Liu YL; Lee CC; Chen WS; Huang TS; Wang TY; Lee AY
Cancer Lett; 2013 Sep; 337(2):218-25. PubMed ID: 23684929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
